Biocytogen Boston Competitors and Similar CompaniesClear all
Biocytogen Boston's competitors and similar companies include Editas Medicine, Caribou Biosciences, Aglaris and CellGenix.
 Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. |  CellGenix CellGenix is a supplier of raw and ancillary materials for the market of cell and gene therapy and regenerative medicine. | |||
Founding Date | Founding Date 2008 | Founding Date 2013 | Founding Date 2012 | Founding Date 2012 | Founding Date 1994 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Waltham, US HQ Beijing, CN Nantong, CN Shanghai, CN Heidelberg, DE San Diego, US San Francisco, US | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Berkeley, US HQ | Locations Stevenage, GB HQ Tres Cantos, ES | Locations Freiburg im Breisgau, DE HQ Newington, US |
Employees | Employees 1833% increase | Employees 20816% increase | Employees 1477% decrease | Employees 13 | Employees 711% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 256.5 m | Valuation ($) 174.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) $11.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($160.1m) (FY, 2025) | Net income ($148.1m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 284.3m | Total funding raised $ 210m | Total funding raised $ 159.5m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Editas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View companyCaribou Biosciences
HQ
Berkeley, US
Employees
147↓ 7% decrease
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company
Aglaris
HQ
Stevenage, GB
Employees
13
Aglaris is a company automating and controlling the cell culture processes.
View companyCellGenix
HQ
Freiburg im Breisgau, DE
Employees
71↑ 1% increase
CellGenix is a supplier of raw and ancillary materials for the market of cell and gene therapy and regenerative medicine.
View company